$AIMT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aimmune Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Aimmune Therapeutics, Inc.. Get notifications about new insider transactions in Aimmune Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Buy | M | 3.02 | 6,591 | 19,918 | 6,720 | 129 to 6.7 K (+5,109.30 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 75,000 | 226,650 | 93,400 | |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 37.75 | 600 | 22,652 | 0 | 600 to 0 (-100.00 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 37.12 | 24,400 | 905,716 | 600 | 25 K to 600 (-97.60 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 37.86 | 300 | 11,359 | 25,000 | 25.3 K to 25 K (-1.19 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 37.13 | 24,700 | 917,022 | 25,300 | 50 K to 25.3 K (-49.40 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 37.78 | 599 | 22,629 | 50,000 | 50.6 K to 50 K (-1.18 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 37.12 | 24,401 | 905,811 | 50,599 | 75 K to 50.6 K (-32.53 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 75,000 | 226,650 | 75,000 | 0 to 75 K |
Dec 29 2017 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | M | 11.45 | 3,283 | 37,590 | 226,717 | |
Dec 29 2017 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Sell | S | 40.00 | 3,283 | 131,320 | 0 | 3.3 K to 0 (-100.00 %) |
Dec 29 2017 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Buy | M | 11.45 | 3,283 | 37,590 | 3,283 | 0 to 3.3 K |
Dec 28 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | M | 3.02 | 75,010 | 226,680 | 120,426 | |
Dec 28 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 39.15 | 3,600 | 140,949 | 129 | 3.7 K to 129 (-96.54 %) |
Dec 28 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 38.73 | 6,400 | 247,848 | 3,729 | 10.1 K to 3.7 K (-63.18 %) |
Dec 28 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 39.28 | 1,200 | 47,134 | 10,129 | 11.3 K to 10.1 K (-10.59 %) |
Dec 28 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 38.83 | 8,800 | 341,663 | 11,329 | 20.1 K to 11.3 K (-43.72 %) |
Dec 28 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 39.26 | 700 | 27,479 | 20,129 | 20.8 K to 20.1 K (-3.36 %) |
Dec 28 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 38.80 | 4,310 | 167,239 | 20,829 | 25.1 K to 20.8 K (-17.14 %) |
Dec 28 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 39.23 | 1,500 | 58,847 | 25,139 | 26.6 K to 25.1 K (-5.63 %) |
Dec 28 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 38.82 | 11,000 | 427,043 | 26,639 | 37.6 K to 26.6 K (-29.23 %) |
Dec 28 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 39.25 | 1,500 | 58,875 | 37,639 | 39.1 K to 37.6 K (-3.83 %) |
Dec 28 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 38.83 | 11,000 | 427,115 | 39,139 | 50.1 K to 39.1 K (-21.94 %) |
Dec 28 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 39.23 | 1,800 | 70,605 | 50,139 | 51.9 K to 50.1 K (-3.47 %) |
Dec 28 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 38.82 | 10,700 | 415,322 | 51,939 | 62.6 K to 51.9 K (-17.08 %) |
Dec 28 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 39.25 | 1,500 | 58,878 | 62,639 | 64.1 K to 62.6 K (-2.34 %) |
Dec 28 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 38.83 | 11,000 | 427,089 | 64,139 | 75.1 K to 64.1 K (-14.64 %) |
Dec 28 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Buy | M | 3.02 | 75,010 | 226,680 | 75,139 | 129 to 75.1 K (+58,147.29 %) |
Dec 28 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 19.63 | 1,875 | 36,806 | 71,250 | |
Dec 28 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 39.44 | 1,875 | 73,950 | 0 | 1.9 K to 0 (-100.00 %) |
Dec 28 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 19.63 | 1,875 | 36,806 | 1,875 | 0 to 1.9 K |
Dec 08 2017 | AIMT | Aimmune Therapeuti ... | Seltzer Stacey Denenberg | Director | Buy | J | 0.00 | 29 | 0 | 29 | 0 to 29 |
Dec 06 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 12.95 | 1,906 | 24,683 | 71,889 | |
Dec 06 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 38.66 | 1,906 | 73,686 | 0 | 1.9 K to 0 (-100.00 %) |
Dec 06 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 12.95 | 1,906 | 24,683 | 1,906 | 0 to 1.9 K |
Dec 04 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 19.63 | 3,750 | 73,613 | 73,125 | |
Dec 04 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 37.00 | 3,750 | 138,750 | 0 | 3.8 K to 0 (-100.00 %) |
Dec 04 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 19.63 | 3,750 | 73,613 | 3,750 | 0 to 3.8 K |
Nov 13 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 12.95 | 1,905 | 24,670 | 73,795 | |
Nov 13 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 33.00 | 1,905 | 62,865 | 0 | 1.9 K to 0 (-100.00 %) |
Nov 13 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 12.95 | 1,905 | 24,670 | 1,905 | 0 to 1.9 K |
Oct 25 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Sell | S | 36.55 | 100 | 3,655 | 315,308 | 315.4 K to 315.3 K (-0.03 %) |
Oct 25 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Sell | S | 35.39 | 6,960 | 246,329 | 315,408 | 322.4 K to 315.4 K (-2.16 %) |
Oct 25 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Sell | S | 34.15 | 17,472 | 596,685 | 322,368 | 339.8 K to 322.4 K (-5.14 %) |
Oct 25 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Sell | S | 33.23 | 75,468 | 2,507,870 | 339,840 | 415.3 K to 339.8 K (-18.17 %) |
Oct 25 2017 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | M | 11.45 | 10,000 | 114,500 | 230,000 | |
Oct 25 2017 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Sell | S | 35.46 | 3,000 | 106,375 | 0 | 3 K to 0 (-100.00 %) |
Oct 25 2017 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Sell | S | 34.27 | 1,470 | 50,384 | 3,000 | 4.5 K to 3 K (-32.89 %) |
Oct 25 2017 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Sell | S | 33.25 | 5,530 | 183,851 | 4,470 | 10 K to 4.5 K (-55.30 %) |
Oct 25 2017 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Buy | M | 11.45 | 10,000 | 114,500 | 10,000 | 0 to 10 K |
Oct 25 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 19.63 | 13,125 | 257,644 | 76,875 | |
Oct 25 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 12.95 | 34,300 | 444,185 | 75,700 | |
Oct 25 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 37.00 | 5,625 | 208,125 | 0 | 5.6 K to 0 (-100.00 %) |
Oct 25 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 35.63 | 7,500 | 267,251 | 5,625 | 13.1 K to 5.6 K (-57.14 %) |
Oct 25 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 19.63 | 13,125 | 257,644 | 13,125 | 0 to 13.1 K |
Oct 25 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 35.34 | 6,333 | 223,826 | 0 | 6.3 K to 0 (-100.00 %) |
Oct 25 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 34.13 | 5,003 | 170,739 | 6,333 | 11.3 K to 6.3 K (-44.13 %) |
Oct 25 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 33.25 | 22,964 | 763,574 | 11,336 | 34.3 K to 11.3 K (-66.95 %) |
Oct 25 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 12.95 | 34,300 | 444,185 | 34,300 | 0 to 34.3 K |
Oct 18 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Sell | S | 26.24 | 1,154 | 30,279 | 415,308 | 416.5 K to 415.3 K (-0.28 %) |
Oct 06 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Sell | S | 26.31 | 4,047 | 106,468 | 416,462 | 420.5 K to 416.5 K (-0.96 %) |
Oct 06 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Sell | S | 26.24 | 14,689 | 385,495 | 420,509 | 435.2 K to 420.5 K (-3.38 %) |
Oct 06 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Sell | S | 26.26 | 30,110 | 790,613 | 435,198 | 465.3 K to 435.2 K (-6.47 %) |
Oct 06 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Sell | S | 26.21 | 50,000 | 1,310,740 | 465,308 | 515.3 K to 465.3 K (-9.70 %) |
Sep 27 2017 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | M | 11.45 | 10,000 | 114,500 | 240,000 | |
Sep 27 2017 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Sell | S | 25.00 | 10,000 | 250,000 | 0 | 10 K to 0 (-100.00 %) |
Sep 27 2017 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Buy | M | 11.45 | 10,000 | 114,500 | 10,000 | 0 to 10 K |
Sep 27 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Sell | S | 25.01 | 100,000 | 2,500,790 | 515,308 | 615.3 K to 515.3 K (-16.25 %) |
Sep 27 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Gift | G | 0.00 | 10,328 | 0 | 20,656 | 10.3 K to 20.7 K (+100.00 %) |
Sep 27 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Gift | G | 0.00 | 10,328 | 0 | 0 | 10.3 K to 0 (-100.00 %) |
Sep 27 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Gift | G | 0.00 | 41,075 | 0 | 41,075 | 0 to 41.1 K |
Sep 27 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Gift | G | 0.00 | 41,075 | 0 | 10,328 | 51.4 K to 10.3 K (-79.91 %) |
Sep 27 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Gift | G | 0.00 | 10,328 | 0 | 10,328 | 0 to 10.3 K |
Sep 27 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Gift | G | 0.00 | 10,328 | 0 | 0 | 10.3 K to 0 (-100.00 %) |
Sep 27 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Gift | G | 0.00 | 41,075 | 0 | 41,075 | 0 to 41.1 K |
Sep 27 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Gift | G | 0.00 | 41,075 | 0 | 10,328 | 51.4 K to 10.3 K (-79.91 %) |
Sep 27 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 20,000 | 60,440 | 168,400 | |
Sep 27 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 25.00 | 20,000 | 500,000 | 0 | 20 K to 0 (-100.00 %) |
Sep 27 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 20,000 | 60,440 | 20,000 | 0 to 20 K |
Sep 11 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | M | 3.02 | 30,000 | 90,660 | 195,436 | |
Sep 11 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 22.50 | 30,000 | 675,000 | 129 | 30.1 K to 129 (-99.57 %) |
Sep 11 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Buy | M | 3.02 | 30,000 | 90,660 | 30,129 | 129 to 30.1 K (+23,255.81 %) |
Sep 07 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 15,167 | 45,835 | 188,400 | |
Sep 07 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 3,223 | 9,740 | 203,567 | |
Sep 07 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 22.00 | 15,167 | 333,709 | 0 | 15.2 K to 0 (-100.00 %) |
Sep 07 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 15,167 | 45,835 | 15,167 | 0 to 15.2 K |
Sep 07 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 22.00 | 3,223 | 70,906 | 0 | 3.2 K to 0 (-100.00 %) |
Sep 07 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 3,223 | 9,740 | 3,223 | 0 to 3.2 K |
Jul 31 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 500 | 1,511 | 206,790 | |
Jul 31 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 22.00 | 500 | 11,000 | 0 | 500 to 0 (-100.00 %) |
Jul 31 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 500 | 1,511 | 500 | 0 to 500 |
Jul 28 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Sell | S | 21.46 | 50,000 | 1,073,110 | 615,308 | 665.3 K to 615.3 K (-7.52 %) |
Jul 25 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 4,650 | 14,052 | 207,290 | |
Jul 25 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 500 | 1,511 | 211,940 | |
Jul 25 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 960 | 2,901 | 212,440 | |
Jul 25 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 22.00 | 4,650 | 102,300 | 0 | 4.7 K to 0 (-100.00 %) |
Jul 25 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 4,650 | 14,052 | 4,650 | 0 to 4.7 K |
Jul 25 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 22.00 | 500 | 11,000 | 0 | 500 to 0 (-100.00 %) |
Jul 25 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 500 | 1,511 | 500 | 0 to 500 |
Jul 25 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 22.00 | 960 | 21,120 | 0 | 960 to 0 (-100.00 %) |
Jul 25 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 960 | 2,901 | 960 | 0 to 960 |
Jul 21 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 21.66 | 7,460 | 161,558 | 0 | 7.5 K to 0 (-100.00 %) |
Jul 17 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | M | 3.02 | 300 | 907 | 225,436 | |
Jul 17 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | M | 3.02 | 5,666 | 17,123 | 225,736 | |
Jul 17 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | M | 3.02 | 8,974 | 27,119 | 231,402 | |
Jul 17 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 21.38 | 300 | 6,414 | 129 | 429 to 129 (-69.93 %) |
Jul 17 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Buy | M | 3.02 | 300 | 907 | 429 | 129 to 429 (+232.56 %) |
Jul 17 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 21.39 | 5,666 | 121,175 | 129 | 5.8 K to 129 (-97.77 %) |
Jul 17 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Buy | M | 3.02 | 5,666 | 17,123 | 5,795 | 129 to 5.8 K (+4,392.25 %) |
Jul 17 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 21.47 | 8,974 | 192,658 | 129 | 9.1 K to 129 (-98.58 %) |
Jul 17 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Buy | M | 3.02 | 8,974 | 27,119 | 9,103 | 129 to 9.1 K (+6,956.59 %) |
Jul 06 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | M | 3.02 | 15,060 | 45,511 | 225,319 | |
Jul 06 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | M | 3.02 | 30,000 | 90,660 | 240,379 | |
Jul 06 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 21.40 | 15,060 | 322,212 | 129 | 15.2 K to 129 (-99.15 %) |
Jul 06 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Buy | M | 3.02 | 15,060 | 45,511 | 15,189 | 129 to 15.2 K (+11,674.42 %) |
Jul 06 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 20.57 | 30,000 | 617,178 | 129 | 30.1 K to 129 (-99.57 %) |
Jul 06 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Buy | M | 3.02 | 30,000 | 90,660 | 30,129 | 129 to 30.1 K (+23,255.81 %) |
Jul 06 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 15,000 | 45,330 | 213,400 | |
Jul 06 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 20.26 | 15,000 | 303,911 | 0 | 15 K to 0 (-100.00 %) |
Jul 06 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 15,000 | 45,330 | 15,000 | 0 to 15 K |
Jun 27 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Sell | S | 20.21 | 49,400 | 998,591 | 665,308 | 714.7 K to 665.3 K (-6.91 %) |
May 30 2017 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Option Exercise | A | 18.26 | 17,500 | 319,550 | 17,500 | |
May 30 2017 | AIMT | Aimmune Therapeuti ... | Seltzer Stacey Denenberg | Director | Option Exercise | A | 18.26 | 17,500 | 319,550 | 17,500 | |
May 30 2017 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 18.26 | 17,500 | 319,550 | 17,500 | |
May 30 2017 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Option Exercise | A | 18.26 | 17,500 | 319,550 | 17,500 | |
May 12 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Sell | S | 20.15 | 600 | 12,090 | 714,708 | 715.3 K to 714.7 K (-0.08 %) |
May 01 2017 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | A | 19.44 | 270,000 | 5,248,800 | 270,000 | |
Apr 06 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Payment of Exercise | F | 21.00 | 4,540 | 95,340 | 7,460 | 12 K to 7.5 K (-37.83 %) |
Apr 05 2017 | AIMT | Aimmune Therapeuti ... | DeSouza Warren L. | Chief Financial Off ... | Option Exercise | M | 3.02 | 15,000 | 45,330 | 303,794 | |
Apr 05 2017 | AIMT | Aimmune Therapeuti ... | DeSouza Warren L. | Chief Financial Off ... | Sell | S | 21.58 | 15,000 | 323,736 | 20,681 | 35.7 K to 20.7 K (-42.04 %) |
Apr 05 2017 | AIMT | Aimmune Therapeuti ... | DeSouza Warren L. | Chief Financial Off ... | Buy | M | 3.02 | 15,000 | 45,330 | 35,681 | 20.7 K to 35.7 K (+72.53 %) |
Mar 23 2017 | AIMT | Aimmune Therapeuti ... | DeSouza Warren L. | Chief Financial Off ... | Option Exercise | M | 3.02 | 10,000 | 30,220 | 318,794 | |
Mar 23 2017 | AIMT | Aimmune Therapeuti ... | DeSouza Warren L. | Chief Financial Off ... | Sell | S | 22.95 | 10,000 | 229,500 | 20,681 | 30.7 K to 20.7 K (-32.59 %) |
Mar 23 2017 | AIMT | Aimmune Therapeuti ... | DeSouza Warren L. | Chief Financial Off ... | Buy | M | 3.02 | 10,000 | 30,220 | 30,681 | 20.7 K to 30.7 K (+48.35 %) |
Feb 24 2017 | AIMT | Aimmune Therapeuti ... | Knapp Jeffrey H | Chief Operating Off ... | Option Exercise | A | 19.63 | 90,000 | 1,766,700 | 90,000 | |
Feb 24 2017 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | A | 19.63 | 90,000 | 1,766,700 | 90,000 | |
Feb 24 2017 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | A | 19.63 | 90,000 | 1,766,700 | 90,000 | |
Feb 24 2017 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Option Exercise | A | 19.63 | 240,000 | 4,711,200 | 240,000 | |
Feb 24 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | A | 19.63 | 90,000 | 1,766,700 | 90,000 | |
Feb 24 2017 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | A | 19.63 | 60,000 | 1,177,800 | 60,000 | |
Feb 03 2017 | AIMT | Aimmune Therapeuti ... | Knapp Jeffrey H | Chief Operating Off ... | Payment of Exercise | F | 17.89 | 2,224 | 39,787 | 2,776 | 5 K to 2.8 K (-44.48 %) |
Jan 13 2017 | AIMT | Aimmune Therapeuti ... | DeSouza Warren L. | Chief Financial Off ... | Option Exercise | M | 3.02 | 20,681 | 62,498 | 328,794 | |
Jan 13 2017 | AIMT | Aimmune Therapeuti ... | DeSouza Warren L. | Chief Financial Off ... | Buy | M | 3.02 | 20,681 | 62,498 | 20,681 | 0 to 20.7 K |
Dec 06 2016 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Buy | J | 0.00 | 129 | 0 | 129 | 0 to 129 |
Dec 01 2016 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | J | 0.00 | 7,276 | 0 | 7,276 | 0 to 7.3 K |
Dec 01 2016 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Sell | J | 0.00 | 1,500,000 | 0 | 6,013,134 | 7.5 M to 6 M (-19.97 %) |
Dec 01 2016 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Buy | J | 0.00 | 7,276 | 0 | 7,276 | 0 to 7.3 K |
Dec 01 2016 | AIMT | Aimmune Therapeuti ... | Longitude Capital Partners II, ... | 10% Owner | Sell | J | 0.00 | 1,500,000 | 0 | 6,013,134 | 7.5 M to 6 M (-19.97 %) |
Nov 28 2016 | AIMT | Aimmune Therapeuti ... | Behar Gregory | Director | Option Exercise | A | 24.90 | 39,510 | 983,799 | 39,510 | |
Nov 15 2016 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 20,000 | 60,440 | 228,400 |